Aveta Biomics and CSIR-CDRI Announce License to Aveta Biomics for the Development and Commercialization of First-in-Class Bone Health Drugs

/PRNewswire/ -- CSIR-Central Drug Research Institute (CDRI), Lucknow, one of the premier drug research institutions in the world and Aveta Biomics, USA, a...

Related Keywords

Boston ,Massachusetts ,United States ,Lucknow ,Uttar Pradesh ,India ,Paragg Mehta ,Kumar Kundu ,Aveta Biomics ,International Osteoporosis Foundation ,Indian Society For Bone ,Endocrinology Division ,Csir Central Drug Research Institute ,National Osteoporosis Foundation ,Mineral Research ,Centre For Disease ,Indian Society ,Ritu Trivedi ,Tapas Kumar Kundu ,Neck Cancer ,Brain Cancer ,Graft Versus Host Diseases ,Central Drug Research Institute ,Prime Minister ,Indian Pharma ,International Osteoporosis ,National Osteoporosis ,Osteoporosis Fast ,Disease Control ,Global Burden ,Disease Study ,Cell Death ,Nc ,